Leukemia Inhibitory Factor and HPV-16 in Cervical Cancer
Author Information
Author(s): Joseph M. Bay, Bruce K. Patterson, Nelson N. H. Teng
Primary Institution: Stanford University School of Medicine
Hypothesis
Can leukemia inhibitory factor (LIF) inhibit the expression of HPV-16 oncogenes and reduce the proliferation of cervical carcinoma cells?
Conclusion
LIF treatment significantly reduces HPV oncogene expression and inhibits the proliferation of cervical cancer cells.
Supporting Evidence
- LIF reduced HPV-16 LCR expression by approximately 60%.
- LIF-treated cells showed significantly reduced levels of E6 and E7 mRNA.
- LIF inhibited the proliferation of cervical cancer cells in a dose-dependent manner.
Takeaway
This study found that a substance called LIF can help stop cancer cells from growing by turning off certain genes that help the cancer grow.
Methodology
Cervical cancer cells were treated with LIF and assessed for proliferation and HPV oncogene expression using various assays.
Limitations
The study primarily focused on specific cervical cancer cell lines, which may not represent all HPV-related cancers.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website